Jeffrey A. Gelfand

Harvard University — United States

Immunology and Microbiology · Life Sciences

48h-index10.0kcitations157works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Response and Inflammation(21), Complement system in diseases(18), Coagulation, Bradykinin, Polyphosphates, and Angioedema(16), Vector-borne infectious diseases(14), Nanoplatforms for cancer theranostics(10)

Publications154 total

Guidance on the Management of Asymptomatic Blood Donors Who Test Positive for <i>Babesia</i>
Clinical Infectious Diseases·2025Open Access
928 VTX-P04, a self-assembling immunotherapy targeting PSCA, induces T cell responses and inhibits TRAMP-C2 tumor growth in a C57BL/6 mouse model of prostate cancer
Regular and Young Investigator Award Abstracts·2025Open Access
Low‐Irradiance Antimicrobial Blue Light‐Bathing Therapy for Wound Infection Control
Advanced Science·2025· 1 citedOpen Access
Developing a translational blue light prototype device for antimicrobial wound treatment
2025
Antimicrobial Blue Light Reduces Human-Wound Pathogens’ Resistance to Tetracycline-Class Antibiotics in Biofilms
Cells·2025· 5 citedOpen Access
An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model
The Journal of Infectious Diseases·2024· 3 citedOpen Access
Adalimumab for the Treatment of CNS Sarcoidosis
Neurology·2024
Antimicrobial blue light-bathing therapy for wound infection control
2024· 1 citedOpen Access
1135 A novel self-assembling vaccine, VTX-067, targeting E6/E7 proteins of human papilloma virus induces T cell immune responses and inhibits HPV E6/E7 expressing tumor growth in a C57/B6 mouse model
Regular and Young Investigator Award Abstracts·2023Open Access
Vitamin K3 (Menadione) is a multifunctional microbicide acting as a photosensitizer and synergizing with blue light to kill drug-resistant bacteria in biofilms
Journal of Photochemistry and Photobiology B Biology·2023· 18 citedOpen Access
Vitamin K3 (Menadione) is a Multifunctional Microbicide Acting as a Photosensitizer with Blue Light to Kill Drug-Resistant Bacteria in Biofilms
SSRN Electronic Journal·2023Open Access
Clofazimine for Babesiosis: Preclinical Data Support a Clinical Trial
The Journal of Infectious Diseases·2021· 4 citedOpen Access
Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head and neck (H&amp;N) cancer.
Journal of Clinical Oncology·2021· 2 cited
Case Report: Overwhelming Babesia Parasitemia Successfully Treated Promptly With RBC Apheresis and Triple Therapy With Clindamycin, Azithromycin, and Atovaquone
Open Forum Infectious Diseases·2020· 7 citedOpen Access
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
The Journal of Infectious Diseases·2020· 79 citedOpen Access
Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital
The FASEB Journal·2020· 153 citedOpen Access
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Nature Biotechnology·2020· 297 citedOpen Access
Clinical Sensitivity and Interpretation of PCR and Serological COVID-19 Diagnostics for Patients Presenting to the Hospital
2020· 17 citedOpen Access
Issue Information
The FASEB Journal·2020Open Access
Test performance evaluation of SARS-CoV-2 serological assays
2020· 253 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

John F. Burke(13), Michael M. Frank(9), Charles A. Dinarello(6), Mark C. Poznansky(6), Seijiro Okusawa(5), C A Dinarello(5), Ronald G. Tompkins(4), Stefan Endres(4), Edouard Vannier(4), Tyler E. Miller(4), Diane Yang(4), Michael G. Astudillo(4), B Bernstein(4), Edward T. Ryan(4), Jochen K. Lennerz(4), James E. Gadek(4), Timothy Brauns(4), Joseph G. Cannon(3), Gerhard Lonnemann(3), John P. Atkinson(3)